Lectins Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC652

Introduction

Lectins are the type of proteins that have the ability to bind carbohydrates and play an important role in immune function, cell to cell adherence, and body fat regulation. The lectins form reverse complexes with mono- or oligosaccharide structures and are extensively used for the purification and characterization of glycoproteins in varied research areas. The major factors driving the growth of market include technological development in the medical research sector and the increased use of lectin based diagnostic approach across healthcare & pharmaceutical industry globally.

Market Dynamics

The increase in use of reliable, quick and cost-effective bioreceptors in biosensing devices and other biochemical tools as well as increasing technological investments by leading players have led to the growth of lectins market globally. However, growing opportunities across Asia-Pacific market; as well as growing healthcare sector are major opportunity areas for the market. The major challenges include health hazards associated with the consumption of bad lectins and threat of substitutes.

Market Classification and Overview

The lectins market is bifurcated on the basis of type, application, end use industry, and geography. The different types of lectins include lentil lectin (LCH), ricinus communis agglutinin (RCA), peanut agglutinin (PNA), and wheat germ agglutinin (WGA) among others. Lentil lectin or LCH is the largest and most mature market as it caters to almost every type of application. Based on application, the market is segmented into biochemical tools and medicine & medical research among others. Biochemical tools is the fastest growing segment owing to the increase in demand for lectin-based biosensors in bioanalytical applications. Based on end use industry, the market is further segmented into healthcare & pharmaceutical, food & beverage and others. Healthcare & pharmaceutical accounts for majority of the global consumption of lectins and led the global lectins end-use industry market followed by food & beverage.

Regional Overview

The market for lectins is segmented into regions such as North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America was the major contributors to the growth of lectins market in 2015. Asia-Pacific was the second biggest market followed by Europe. The market in Asia-Pacific is further projected to witness highest growth in coming years owing to the growth of healthcare industry in the region. The North America market for lectins is likely to grow at a significant rate owing to the increase in demand for antimicrobial proteins in healthcare industry in the region.

Report Coverage

Market

Lectins Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Application, End-use industry, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

EY Laboratories, Medicago, Vector Laboratories, Cosmo Bio, Vector Laboratories, Plasmatech Laboratory Products, Abbexa Ltd, DSHBUS, Lifespan Biosciences, and Fitzgerald Industries International are the key players in lectins market. These players involved have adopted the strategies including mergers and acquisitions with local as well as established players.

Market Segmentation

Market By Type

  • Lentil Lectin (LCH)
  • Ricinus Communis Agglutinin (RCA)
  • Peanut Agglutinin (PNA)
  • Wheat Germ Agglutinin (WGA)
  • Others

Market By Application

  • Biochemical Tools
  • Medicine and Medical Research
  • Others

Market By End-Use Industry

  • Healthcare & Pharmaceutical
  • Food & Beverage
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary